Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Model May Predict Final Menstrual Period

By HospiMedica International staff writers
Posted on 09 Apr 2013
A new mathematical model based on the levels of two hormones can predict when perimenopausal women will have their final period, according to a new study.

Researchers at the University of California Los Angeles (UCLA; USA) and the University of Tokyo (Japan) conducted a cohort study involving 554 women to examine whether a model that takes into account levels of follicle-stimulating hormone (FSH), estradiol, or urinary N-telopeptide could predict where an individual is on her timeline to final menstrual period (FMP). More...
The researchers examined specified landmarks—2 years before, 1 year before, and the FMP—and determined the candidate markers that best predicted having crossed each landmark.

The researchers used the data to create formulas for the probability of having crossed each landmark, and calculated sensitivity and specificity. The final models included current estradiol and FSH, age, menopause transition stage, race/ethnicity, and whether serum was collected during the early follicular phase. The resulting model predicted the likelihood of perimenopausal women being two years away from their final period with 85% sensitivity and 77% specificity. The study was published ahead of print on March 26, 2013, in the Journal of Clinical Endocrinology & Metabolism.

“The model's discrimination—its ability to correctly rank women according to whether or not they had crossed a landmark—was excellent,” concluded lead author Gail Greendale, MD, of UCLA, and colleagues. “If further research bears out our approach, it could be the first step to developing web-based calculators and other tools women can use to estimate where they are in the menopause transition and how far away their final period is.”

Researchers have long been trying to find a way to predict when a woman's FMP will occur, since it can help determine the risk of other biological changes, including accelerated bone loss, which tends to happen in the final year of menstruation; starting an intervention one or two years before the FMP could lower future fracture risk.

Related Links:

University of California Los Angeles
University of Tokyo



Gold Member
12-Channel ECG
CM1200B
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Electric Bed
DIXION Intensive Care Bed
VTE Prevention System
Flowtron ACS900
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Business

view channel
Image: The collaboration will integrate Masimo’s innovations into Philips’ multi-parameter monitoring platforms (Photo courtesy of Royal Philips)

Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies

Royal Philips (Amsterdam, Netherlands) and Masimo (Irvine, California, USA) have renewed their multi-year strategic collaboration, combining Philips’ expertise in patient monitoring with Masimo’s noninvasive... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.